Evaluation of Developmental Toxicants and Signaling Pathways in a Functional Test Based on the Migration of Human Neural Crest Cells

Background: Information on the potential developmental toxicity (DT) of the majority of chemicals is scarce, and test capacities for further animal-based testing are limited. Therefore, new approaches with higher throughput are required. A screening strategy based on the use of relevant human cell types has been proposed by the U.S. Environmental Protection Agency and others. Because impaired neural crest (NC) function is one of the known causes for teratologic effects, testing of toxicant effects on NC cells is desirable for a DT test battery. Objective: We developed a robust and widely applicable human-relevant NC function assay that would allow for sensitive screening of environmental toxicants and defining toxicity pathways. Methods: We generated NC cells from human embryonic stem cells, and after establishing a migration assay of NC cells (MINC assay), we tested environmental toxicants as well as inhibitors of physiological signal transduction pathways. Results: Methylmercury (50 nM), valproic acid (> 10 µM), and lead-acetate [Pb(CH3CO2)4] (1 µM) affected the migration of NC cells more potently than migration of other cell types. The MINC assay correctly identified the NC toxicants triadimefon and triadimenol. Additionally, it showed different sensitivities to various organic and inorganic mercury compounds. Using the MINC assay and applying classic pharmacologic inhibitors and large-scale microarray gene expression profiling, we found several signaling pathways that are relevant for the migration of NC cells. Conclusions: The MINC assay faithfully models human NC cell migration, and it reveals impairment of this function by developmental toxicants with good sensitivity and specificity.

[1]  Leah C. Fuller,et al.  Neural crest cell motility in valproic acid. , 2002, Reproductive toxicology.

[2]  C. Pollack,et al.  Heavy metal toxicity, Part I: arsenic and mercury. , 1998, The Journal of emergency medicine.

[3]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[4]  P. Rørth,et al.  Collective cell migration. , 2009, Annual review of cell and developmental biology.

[5]  A. Viale,et al.  Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.

[6]  M. Swiet Drugs and pregnancy: human teratogenesis and related problems. , 1983, Archives of Disease in Childhood.

[7]  Leonora Buzanska,et al.  Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. , 2011, ALTEX.

[8]  Shin Ishii,et al.  Collective Cell Migration , 2013 .

[9]  M. Kirby,et al.  PCB126 exposure disrupts zebrafish ventricular and branchial but not early neural crest development. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  Sac-fry Stages,et al.  OECD GUIDELINE FOR TESTING OF CHEMICALS , 2002 .

[11]  Marcel Leist,et al.  Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  Nathalie Delrue,et al.  A Retrospective Performance Assessment of the Developmental Neurotoxicity Study in Support of OECD Test Guideline 426 , 2008, Environmental health perspectives.

[13]  Robert J Kavlock,et al.  Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  P. Trainor Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention , 2010, American journal of medical genetics. Part A.

[15]  Thomas Dino Rockel,et al.  Human Neurospheres as Three-Dimensional Cellular Systems for Developmental Neurotoxicity Testing , 2009, Environmental health perspectives.

[16]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[17]  R. Pennati,et al.  Action of valproic acid on Xenopus laevis development: teratogenic effects on eyes. , 2001, Teratogenesis, carcinogenesis, and mutagenesis.

[18]  S. Makris,et al.  The use of developmental neurotoxicity data in pesticide risk assessments. , 2009, Neurotoxicology and teratology.

[19]  G. Bernardini,et al.  Triadimefon Causes Branchial Arch Malformations in Xenopus laevis Embryos (5 pp) , 2006, Environmental science and pollution research international.

[20]  N. Socci,et al.  BAC Transgenesis in Human Embryonic Stem Cells as a Novel Tool to Define the Human Neural Lineage , 2009, Stem cells.

[21]  E. Silbergeld,et al.  Methylmercury-induced decrement in neuronal migration may involve cytokine-dependent mechanisms: a novel method to assess neuronal movement in vitro. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  Jonathan A. Lee,et al.  A Quantitative, Facile, and High-Throughput Image-Based Cell Migration Method Is a Robust Alternative to the Scratch Assay , 2011, Journal of biomolecular screening.

[23]  Guang Chen,et al.  Mood Stabilizer Valproate Promotes ERK Pathway-Dependent Cortical Neuronal Growth and Neurogenesis , 2004, The Journal of Neuroscience.

[24]  N. Saunders,et al.  Developmental neurotoxicity of industrial chemicals , 2007, The Lancet.

[25]  U. Hass The need for developmental neurotoxicity studies in risk assessment for developmental toxicity. , 2006, Reproductive toxicology.

[26]  F. Pulzer,et al.  Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro. , 2001, Anticancer research.

[27]  B. Padnos,et al.  Developmental exposure to valproate and ethanol alters locomotor activity and retino-tectal projection area in zebrafish embryos. , 2012, Reproductive toxicology.

[28]  D. Spitkovsky,et al.  Effects of Cryopreservation on the Transcriptome of Human Embryonic Stem Cells After Thawing and Culturing , 2011, Stem Cell Reviews and Reports.

[29]  L. Tsai,et al.  The Mood Stabilizers Valproic Acid and Lithium Enhance Mesenchymal Stem Cell Migration via Distinct Mechanisms , 2010, Neuropsychopharmacology.

[30]  Marcel Leist,et al.  Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[31]  A. Fucic,et al.  Today's epidemics in children: Possible relations to environmental pollution and suggested preventive measures , 2006, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[32]  Steven K. Gibb Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[33]  M. Tomishima,et al.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.

[34]  Crispin J. Miller,et al.  Cell Culture , 2010, Cell.

[35]  E. Dupin,et al.  The stem cells of the neural crest , 2008, Cell cycle.

[36]  P. Friedl,et al.  The Journal of Cell Biology , 2002 .

[37]  E. Menegola,et al.  In vitro teratogenic potential of two antifungal triazoles: Triadimefon and triadimenol , 2000, In Vitro Cellular & Developmental Biology - Animal.

[38]  Harvey J Clewell,et al.  Can case study approaches speed implementation of the NRC report: "toxicity testing in the 21st century: a vision and a strategy?". , 2011, ALTEX.

[39]  P. Schwartz,et al.  Human Pluripotent Stem Cells , 2011, Methods in Molecular Biology.

[40]  W. Koh,et al.  Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing , 2011, Cell Death and Differentiation.

[41]  E. Menegola,et al.  Antifungal triazole derivative triadimefon induces ectopic maxillary cartilage by altering the morphogenesis of the first branchial arch. , 2007, Birth defects research. Part B, Developmental and reproductive toxicology.

[42]  P. Thorogood Embryos, genes and birth defects. , 1997 .

[43]  Georgia Panagiotakos,et al.  Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells , 2007, Nature Biotechnology.

[44]  Hedi Peterson,et al.  g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments , 2007, Nucleic Acids Res..

[45]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[46]  H Nau,et al.  Species differences in pharmacokinetics and drug teratogenesis. , 1986, Environmental health perspectives.

[47]  Thomas Hartung,et al.  Chemical regulators have overreached , 2009, Nature.